QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

New name and stock symbol represents therapeutic focus on inhibiting TNF-alpha to regulate the immuno-metabolic system

 mymd-pharmaceuticals-announces-corporate-rebranding-to-new-name-tnf-pharmaceuticals-to-begin-under-the-new-trading-symbol-tnfa-effective-july-24-2024

New name represents therapeutic focus on inhibiting TNF-alpha to regulate the immuno-metabolic systemCompany plans mid-stage cl...

 latest-key-hires--board-changes-in-cannabis-industry-canopy-growth-acreage-and-more

s Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 its 19th edition, gathering top CEOs, investors and inv...

Core News & Articles

Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to cr...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 mymd-pharmaceuticals-filing-from-late-monday-shows-co-entered-omnibus-waiver-and-amendment-agreement-with-required-holders-under-previously-announced-securities-purchase-agreement

As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Pur...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 mymd-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company...

 mymd-pharmaceuticals-announces-1-for-30-reverse-stock-split-to-maintain-nasdaq-listing

Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyM...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION